Redona Therapeutics

📍 Watertown, United States🗓 Founded 2016👥 22 employees💰 Last funded Jan 2020
Biotechnology Research🌐 redonatx.com
Website LinkedIn
Redona Therapeutics is focused on the modulation of functional non-coding RNA (ncRNA) to treat cancer and other human diseases. By targeting ncRNA modulating proteins (RMPs), we can use small molecules to modulate expression levels of oncogenes and other proteins of significance in disease.
2
Total investors
1
Early stage
1
Mid stage
0
Late stage
2016
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Redona Therapeutics?
Redona Therapeutics has 2 investors on record on gritt.io, including 1 early-stage backers, 1 mid-stage.
When did Redona Therapeutics last raise funding?
The most recent investment in Redona Therapeutics recorded on gritt.io was in January 2020.
When was Redona Therapeutics founded?
Redona Therapeutics was founded in 2016.
What industry is Redona Therapeutics in?
Redona Therapeutics operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.
Where is Redona Therapeutics based?
Redona Therapeutics is headquartered in Watertown, United States.